U.S. Stock Futures Lower as Oil Surges Above $100
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 13 2026
0mins
Should l Buy LEG?
Stock futures are lower across the board this morning as investors adjust to a renewed U.S.-Iran escalation scenario. Markets are starting the week on the back foot after the weekend collapse in peace negotiations.Crude has surged back above $100 following the announcement of a potential U.S. naval blockade around Iranian shipping routes. Volatility is ticking higher and safe-haven flows are creeping back into the dollar. Energy stocks are bid on higher crude, while airlines and travel names are under pressure as fuel costs spike. At the same time, markets are showing a degree of resilience. Earnings season is kicking off with major banks leading this week, which introduces another layer. Up to this point, macro and geopolitics have been the main drivers.In pre-market trading, S&P 500 futures fell 0.50%, Nasdaq futures fell 0.44% and Dow futures fell 1.00%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Allogene Therapeuticsup 61% after reporting data from the planned interim futility analysis of its randomized Phase 2 ALPHA3 trialRevolution Medicinesup 33% after announcing topline results from its controlled Phase 3 RASolute 302 clinical trialLeggett & Plattup 8% after Somnigroupand the company announced that the companies have signed a definitive agreement pursuant to which Somnigroup will acquire Leggett & Platt in an all-stock transaction valued at approximately $2.5BWilliams-Sonomaup 2% after Goldman Sachs upgraded the stock to Buy from Neutral with a price target of $218, up from $185Baker Hughesup 1% after announcing that it has entered into an agreement to sell its Waygate Technologies business to HexagonToll Brothersup 1% after Evercore ISI upgraded shares to Outperform from In Line with a price target of $176, up from $174DOWN AFTER EARNINGS -Goldman Sachsdown 4%Fastenaldown 2%LOWER -Best Buydown 4% after Goldman Sachs double downgraded the stock to Sell from Buy with a price target of $59, down from $76Somnigroupdown 1% after the company and Leggett & Platt announced that the companies have signed a definitive agreement pursuant to which Somnigroup will acquire Leggett & Platt in an all-stock transaction valued at approximately $2.5B
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LEG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LEG
Wall Street analysts forecast LEG stock price to rise
3 Analyst Rating
0 Buy
3 Hold
0 Sell
Hold
Current: 11.160
Low
11.00
Averages
12.00
High
13.00
Current: 11.160
Low
11.00
Averages
12.00
High
13.00
About LEG
Leggett & Platt, Incorporated is a diversified manufacturer that designs and produces a variety of engineered components and products that can be found in homes and automobiles. Its segments include Bedding Products, Specialized Products and Furniture, Flooring & Textile Products. Bedding Products segment supplies a variety of components and machinery used by bedding manufacturers, as well as produces private label finished mattresses and adjustable bed bases. This segment is also vertically integrated into the production and supply of specialty foam chemicals, steel rod, and drawn steel wire to its own operations and to external customers. Specialized Products segment supplies lumbar support systems, seat suspension systems, motors and actuators, and control cables used by automotive manufacturers. Furniture, Flooring & Textile Products segment supplies a range of components for residential and work furniture manufacturers, as well as select lines of private label finished furniture.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Avanos Medical, Inc. (NYSE: AVNS) for potential violations of federal securities laws related to its sale to American Industrial Partners for $25.00 per share in cash, raising concerns about fiduciary duties to shareholders.
- Shareholder Rights: Leggett & Platt, Incorporated (NYSE: LEG) is set to sell to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per Leggett share, resulting in Leggett shareholders owning approximately 9% of the combined entity, with Halper Sadeh LLC encouraging shareholders to explore their rights and options.
- Cash Transaction: Soleno Therapeutics, Inc. (NASDAQ: SLNO) plans to sell to Neurocrine Biosciences for $53.00 per share in cash, prompting Halper Sadeh LLC to remind shareholders of their potential legal rights.
- Management Involvement: Forian Inc. (NASDAQ: FORA) is being sold for $2.17 per share in cash to a consortium led by CEO Max Wygod, with Halper Sadeh LLC potentially seeking increased consideration and other remedies to protect shareholder interests.
See More
Investigations into Multiple Medical Company Mergers
- Avanos Medical Acquisition: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in an all-cash deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Leggett & Platt Merger: Leggett & Platt will be acquired by Somnigroup International in an all-stock transaction valued at around $2.5 billion, where shareholders will receive 0.1455 shares of Somnigroup for each share of Leggett & Platt, raising concerns about potential fiduciary breaches by the board.
- Soleno Therapeutics Acquisition: Soleno is to be acquired by Neurocrine Biosciences for $53.00 per share in cash, representing a total equity value of approximately $2.9 billion, with investigations questioning the fairness of the deal given it is below the company's 52-week high of $90.32.
- Forian, Inc. Investigation: Forian will be acquired by an entity affiliated with CEO Max Wygod for $2.17 per share in cash, with investigations looking into whether the board failed to conduct a fair process, potentially impacting shareholder value.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Avanos Medical, Inc.'s sale to American Industrial Partners for $25.00 per share in cash, which may infringe on shareholder rights.
- Transaction Structure Analysis: Leggett & Platt, Incorporated is selling to Somnigroup International Inc. for 0.1455 shares of common stock per share, resulting in Leggett & Platt shareholders owning approximately 9% of the combined company, potentially affecting their future equity.
- Cash Transaction Impact: Assertio Holdings, Inc. is being sold to Garda Therapeutics for $18.00 per share in cash and a contingent value right, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures to protect shareholder interests.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, aiming to provide relief for investors affected by securities fraud and corporate misconduct, emphasizing their expertise in safeguarding investor rights.
See More
U.S. Stocks Close Higher, Led by Tech Sector Gains
- Tech Sector Rally: Oracle's stock surged over 12%, leading a rebound in software stocks that propelled the overall market higher, indicating investor confidence in the tech sector's recovery, which may attract more capital inflows into this area.
- Economic Data Impact: U.S. March existing home sales fell 3.6% month-over-month to a 9-month low of 3.98 million, below the expected 4.05 million, and this weak data could influence the Fed's monetary policy decisions, increasing market expectations for rate cuts.
- Oil Price Volatility: Following President Trump's announcement of a full naval blockade of the Strait of Hormuz, WTI crude prices rose over 2%, although still below early highs, which could exacerbate global oil and fuel shortages, impacting related industry stock performance.
- Upcoming Earnings Season: Q1 earnings for the S&P 500 are projected to climb 12% year-over-year, but excluding the tech sector, earnings growth is only expected to be around 3%, the weakest in two years, reflecting market caution regarding profit growth.
See More
Mixed US Stock Performance Amid Soaring Oil Prices
- Oil Price Surge Impacts Market: Following President Trump's order to blockade the Strait of Hormuz, crude oil prices surged over 5%, putting pressure on the stock market, particularly affecting airline and cruise line stocks, indicating potential threats to corporate profits from oil price volatility.
- Software Stocks Rebound: Oracle's stock jumped over 8%, leading a rebound in software stocks, suggesting a positive market response to its newly launched utilities industry solutions, which may enhance the company's position in a competitive market.
- Weak Economic Data: March existing home sales in the US fell 3.6% month-over-month to a nine-month low of 3.98 million, below the expected 4.05 million, indicating weakness in the housing market that could negatively impact overall economic growth.
- Earnings Season Outlook: Q1 earnings for the S&P 500 are projected to rise 12% year-over-year, but excluding the technology sector, the increase is only 3%, the lowest in two years, reflecting cautious market sentiment regarding future profitability.
See More
Oil Price Surge Triggers Market Volatility
- Oil Price Surge: Following President Trump's order for a full naval blockade of the Strait of Hormuz, WTI crude oil prices have surged over 7%, which could exacerbate global oil and fuel shortages, impacting market supply-demand dynamics.
- Mixed Market Performance: While the S&P 500 index is up 0.05%, the Dow Jones Industrial Average has fallen by 0.39%, indicating market sensitivity to oil price fluctuations that may lead to investor sentiment instability.
- Earnings Expectations: According to Bloomberg Intelligence, Q1 earnings for the S&P 500 are projected to rise by 12% year-over-year, but excluding the technology sector, the increase is only 3%, highlighting overall earnings growth weakness.
- Airline Stocks Decline: Due to rising oil prices, airline and cruise line stocks have generally fallen, with Carnival and Norwegian Cruise Line both down over 3%, reflecting the potential threat of high oil prices on corporate profits.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Avanos Medical, Inc. (NYSE: AVNS) for potential violations of federal securities laws related to its sale to American Industrial Partners for $25.00 per share in cash, raising concerns about fiduciary duties to shareholders.
- Shareholder Rights: Leggett & Platt, Incorporated (NYSE: LEG) is set to sell to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock per Leggett share, resulting in Leggett shareholders owning approximately 9% of the combined entity, with Halper Sadeh LLC encouraging shareholders to explore their rights and options.
- Cash Transaction: Soleno Therapeutics, Inc. (NASDAQ: SLNO) plans to sell to Neurocrine Biosciences for $53.00 per share in cash, prompting Halper Sadeh LLC to remind shareholders of their potential legal rights.
- Management Involvement: Forian Inc. (NASDAQ: FORA) is being sold for $2.17 per share in cash to a consortium led by CEO Max Wygod, with Halper Sadeh LLC potentially seeking increased consideration and other remedies to protect shareholder interests.
See More
Investigations into Multiple Medical Company Mergers
- Avanos Medical Acquisition: Avanos Medical is set to be acquired by American Industrial Partners for $25.00 per share in an all-cash deal valued at approximately $1.272 billion, with investigations focusing on whether the board breached fiduciary duties by failing to ensure a fair process for shareholders.
- Leggett & Platt Merger: Leggett & Platt will be acquired by Somnigroup International in an all-stock transaction valued at around $2.5 billion, where shareholders will receive 0.1455 shares of Somnigroup for each share of Leggett & Platt, raising concerns about potential fiduciary breaches by the board.
- Soleno Therapeutics Acquisition: Soleno is to be acquired by Neurocrine Biosciences for $53.00 per share in cash, representing a total equity value of approximately $2.9 billion, with investigations questioning the fairness of the deal given it is below the company's 52-week high of $90.32.
- Forian, Inc. Investigation: Forian will be acquired by an entity affiliated with CEO Max Wygod for $2.17 per share in cash, with investigations looking into whether the board failed to conduct a fair process, potentially impacting shareholder value.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Avanos Medical, Inc.'s sale to American Industrial Partners for $25.00 per share in cash, which may infringe on shareholder rights.
- Transaction Structure Analysis: Leggett & Platt, Incorporated is selling to Somnigroup International Inc. for 0.1455 shares of common stock per share, resulting in Leggett & Platt shareholders owning approximately 9% of the combined company, potentially affecting their future equity.
- Cash Transaction Impact: Assertio Holdings, Inc. is being sold to Garda Therapeutics for $18.00 per share in cash and a contingent value right, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures to protect shareholder interests.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, aiming to provide relief for investors affected by securities fraud and corporate misconduct, emphasizing their expertise in safeguarding investor rights.
See More
U.S. Stocks Close Higher, Led by Tech Sector Gains
- Tech Sector Rally: Oracle's stock surged over 12%, leading a rebound in software stocks that propelled the overall market higher, indicating investor confidence in the tech sector's recovery, which may attract more capital inflows into this area.
- Economic Data Impact: U.S. March existing home sales fell 3.6% month-over-month to a 9-month low of 3.98 million, below the expected 4.05 million, and this weak data could influence the Fed's monetary policy decisions, increasing market expectations for rate cuts.
- Oil Price Volatility: Following President Trump's announcement of a full naval blockade of the Strait of Hormuz, WTI crude prices rose over 2%, although still below early highs, which could exacerbate global oil and fuel shortages, impacting related industry stock performance.
- Upcoming Earnings Season: Q1 earnings for the S&P 500 are projected to climb 12% year-over-year, but excluding the tech sector, earnings growth is only expected to be around 3%, the weakest in two years, reflecting market caution regarding profit growth.
See More
Mixed US Stock Performance Amid Soaring Oil Prices
- Oil Price Surge Impacts Market: Following President Trump's order to blockade the Strait of Hormuz, crude oil prices surged over 5%, putting pressure on the stock market, particularly affecting airline and cruise line stocks, indicating potential threats to corporate profits from oil price volatility.
- Software Stocks Rebound: Oracle's stock jumped over 8%, leading a rebound in software stocks, suggesting a positive market response to its newly launched utilities industry solutions, which may enhance the company's position in a competitive market.
- Weak Economic Data: March existing home sales in the US fell 3.6% month-over-month to a nine-month low of 3.98 million, below the expected 4.05 million, indicating weakness in the housing market that could negatively impact overall economic growth.
- Earnings Season Outlook: Q1 earnings for the S&P 500 are projected to rise 12% year-over-year, but excluding the technology sector, the increase is only 3%, the lowest in two years, reflecting cautious market sentiment regarding future profitability.
See More
Oil Price Surge Triggers Market Volatility
- Oil Price Surge: Following President Trump's order for a full naval blockade of the Strait of Hormuz, WTI crude oil prices have surged over 7%, which could exacerbate global oil and fuel shortages, impacting market supply-demand dynamics.
- Mixed Market Performance: While the S&P 500 index is up 0.05%, the Dow Jones Industrial Average has fallen by 0.39%, indicating market sensitivity to oil price fluctuations that may lead to investor sentiment instability.
- Earnings Expectations: According to Bloomberg Intelligence, Q1 earnings for the S&P 500 are projected to rise by 12% year-over-year, but excluding the technology sector, the increase is only 3%, highlighting overall earnings growth weakness.
- Airline Stocks Decline: Due to rising oil prices, airline and cruise line stocks have generally fallen, with Carnival and Norwegian Cruise Line both down over 3%, reflecting the potential threat of high oil prices on corporate profits.
See More
